Avidity Partners Management LP Arvinas, Inc. Transaction History

Avidity Partners Management LP

$885 Million
Q4 2024

A detailed history of Avidity Partners Management LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 1,358,000 shares of ARVN stock, worth $11.9 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares

1,358,000

Previous 1,497,000 9.29%

Holding current value

$11.9 Million

Previous $36.9 Million 29.4%

% of portfolio

2.94%

Previous 2.26%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$17.83 - $28.04 $2.48 Million - $3.9 Million	-139,000 Reduced 9.29%	1,358,000 $26 Million
Q3 2024 Nov 14, 2024	SELL	$23.66 - $32.73 $35.3 Million - $48.8 Million	-1,490,845 Reduced 49.9%	1,497,000 $36.9 Million
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $64,941 - $107,262	2,655 Added 0.09%	2,987,845 $79.5 Million
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $2,655 - $3,818	73 Added 0.0%	2,985,190 $123 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $5.25 Million - $15.7 Million	370,157 Added 14.16%	2,985,117 $123 Million
Q3 2023 Nov 14, 2023	SELL	$19.64 - $28.21 $3.11 Million - $4.46 Million	-158,229 Reduced 5.71%	2,614,960 $51.4 Million
Q2 2023 Aug 14, 2023	SELL	$21.73 - $31.43 $32.6 Million - $47.2 Million	-1,500,711 Reduced 35.11%	2,773,189 $68.8 Million
Q1 2023 May 15, 2023	SELL	$26.15 - $37.26 $17.7 Million - $25.2 Million	-676,100 Reduced 13.66%	4,273,900 $117 Million
Q4 2022 Feb 14, 2023	BUY	$32.47 - $57.24 $19.7 Million - $34.7 Million	606,500 Added 13.96%	4,950,000 $169 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $41.4 Million - $57.3 Million	987,877 Added 29.44%	4,343,500 $193 Million
Q2 2022 Aug 15, 2022	BUY	$36.01 - $74.24 $15.9 Million - $32.7 Million	440,323 Added 15.1%	3,355,623 $141 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $23.3 Million - $31.6 Million	387,327 Added 15.32%	2,915,300 $196 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $19.3 Million - $28.2 Million	293,273 Added 13.12%	2,527,973 $208 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $27.9 Million - $41.1 Million	380,700 Added 20.53%	2,234,700 $184 Million
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $5.66 Million - $7.9 Million	93,700 Added 5.32%	1,854,000 $143 Million
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $1.57 Million - $2.47 Million	-27,058 Reduced 1.51%	1,760,300 $116 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $8.86 Million - $37.3 Million	439,058 Added 32.56%	1,787,358 $152 Million
Q3 2020 Nov 16, 2020	BUY	$22.99 - $36.34 $6.24 Million - $9.86 Million	271,400 Added 25.2%	1,348,300 $31.8 Million
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $32.2 Million - $61.1 Million	1,076,900 New	1,076,900 $36.1 Million

Others Institutions Holding ARVN

# of Institutions

224

Shares Held

70.9M

Call Options Held

1.52M

Put Options Held

346K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $466M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Account

Avidity Partners Management LP Arvinas, Inc. Transaction History